Novavax, Inc. (NASDAQ:NVAX) traded at $12.62 at close of the session on current trade day and made an upward move of 0.72% on its previous day’s price. Looking at the stock we see that its previous close was $12.53 and the beta (5Y monthly) reads
Shares of US biotech company Novavax at the August 5 aftermarket trading rose 5%, then plunged more than 17% to $204.76 each. The plunge was in response to the upcoming transfer of the application to the United States Food and Drug Administration (FDA) for approval
In the biotechnology industry, companies produce drugs that treat illness and diagnostic technologies. For these products to be approved by the FDA, the process is lengthy and expensive. Food and Drug Administration (FDA). In this case, investors may have to wait years to find out
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
